| Drug Name |
Fomepizole |
| Drug ID |
BADD_D00956 |
| Description |
Fomepizole is used as an antidote in confirmed or suspected methanol or ethylene glycol poisoning. Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites. |
| Indications and Usage |
Antizol is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis |
| Marketing Status |
approved; vet_approved |
| ATC Code |
V03AB34 |
| DrugBank ID |
DB01213
|
| KEGG ID |
D00707
|
| MeSH ID |
D000077604
|
| PubChem ID |
3406
|
| TTD Drug ID |
D02NJA
|
| NDC Product Code |
0517-0710; 50384-0600; 70710-1478; 65732-702; 14096-107; 17511-101; 67457-211; 68083-510; 76339-106; 68475-510 |
| UNII |
83LCM6L2BY
|
| Synonyms |
Fomepizole | 4-Methylpyrazole | 4 Methylpyrazole | Antizol | 4-Methylpyrazole Monohydrochloride | 4 Methylpyrazole Monohydrochloride |
